Lawmakers scrutinized 23andMe’s data privacy practices and the potential national security risks associated with the sale of genetic data. Concerns include consumer consent, data security, and the ethical implications of selling sensitive DNA information to third parties. #23andMe #GeneticData #DataPrivacy #NationalSecurity
Keypoints
- Lawmakers questioned 23andMe’s handling of consumer genetic data and the potential security risks involved.
- The company’s pending sale has raised concerns over lack of customer opt-in options for data sharing.
- 23andMe asserts that it adheres to its privacy policies, but the future buyer’s compliance remains uncertain.
- Consumers face difficulties deleting their genetic data, which could be sold or misused.
- Regulatory and ethical issues surrounding genetic data sales highlight the need for stronger federal privacy laws.
Read More: https://therecord.media/23andme-leadership-grilled-by-lawmakers-hearing